Long COVID Patient Symptoms and its Evaluation and Management

Journal of Nepal Medical Association

Richard Love¹  Deepak Sundar Shrestha² 

[1] Department of Computer Science, Marquette University, Milwaukee, Wisconsin, United States of America;Department of Internal Medicine, People’s Dental College and Hospital, Kathmandu, Nepal;

关键词: chronic fatigue syndrome;    COVID-19;    immune system diseases;    hypothalamic hormones.;   

DOI  :  10.31729/jnma.6355

来源: DOAJ

【 摘 要 】

While the acute case burdens and deaths from the COVID-19 pandemic (in Nepal approaching 700,000 and 10,000 respectively) have been costly, the characteristics and potentially huge dimensions of the chronic disease sequelae of this infectious disease are only slowly becoming apparent. We reviewed Pub Med, major medical meeting and medical journal, and investigative journalist materials seeking to frame and describe COVID-19 chronic disease. The consequences of COVID-19 infections follow major organ damage, and induction of immunological and hormonal systems dysfunction. The first injuries are consequent to direct viral effects on tissues, and vasculitis, endothelialitis, thrombosis and inflammatory events. Pulmonary, cardiac, brain, and kidney tissues incur function-limiting damage, with dyspnea, arrythmias, decreased exercise capacity, cognitive dysfunction, and decreased glomerular filtration rates. The second process is characterized by immune dysregulation and autoimmunity, and dysfunction of hormonal regulation systems, with high, fluctuating levels of physical and mental fatigue, multiple-site pain and ache, and non-restorative sleep, in 10-30% of cases. This communication proposes evaluation and management of chronic COVID-19 patients with efficient assessment of commonest symptoms, targeted physical examination and organ function testing, and interventions based on specific organ functional status, and experience with similar chronic immune syndromes, such as myalgic encephalomyelitis.

【 授权许可】

Unknown